Fighting breast cancer using membrane-active peptides

Detalhes bibliográficos
Autor(a) principal: Almeida, Inês Filipa de Oliveira
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/19894
Resumo: Cancer is still one of the major death causes worldwide demanding an urgent search for new therapies that combine selectivity, efficacy and ability to avoid resistance by cancer cells. One of the biggest advances in anticancer therapy is the use of antimicrobial peptides’ (AMPs) as chemotherapy drugs since some of them showed both antimicrobial activity and selective anticancer activity. In this work, the anticancer activity of three different AMPs, pepR, HNP-1 and PvD1, was tested against cancer and non-tumorigenic breast cell lines (MDA-MB-231 and MCF 10A). The cytotoxic activity of each peptide was evaluated by MTT tetrazolium assay and the determination of the half maximal inhibitory concentration (IC50), and showed that pepR and PvD1 act as anticancer peptides (ACPs), able to select between cancer and non-tumorigenic cells, whereas HNP-1 is not a promising ACP once it is not selective, killing both cell lines at the same concentration. Then, zeta-potential was used to evaluate the peptide-cell interaction and its effect in cells’ surface charge. In this case, surface neutralization is not required before cell death, contrary to what happens when these peptides act like AMPs. Finally, according with previous results, PvD1 was chosen as the most promising peptide and, as such, used for imaging assays with atomic force microscopy (AFM). With this technique height profiles and surface roughness were evaluated for both cell lines in absence and presence of three different PvD1 concentrations. It was concluded that, with the increase of peptide concentration there are no significant changes in cell’s height profiles. On the other hand, when analysed separately, nucleus and cytoplasm present surface roughness changes associated to the increasing of PvD1 concentration. Although it is not yet possible to propose a mechanism of action, both pepR and PvD1 are efficient against MDA-MB-231 cells and selective to MCF 10A cells.
id RCAP_5c4d875b51c29cbed5ceb731e2501be0
oai_identifier_str oai:run.unl.pt:10362/19894
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Fighting breast cancer using membrane-active peptidesAnticancer peptideBreast cancerMembrane surface chargeAtomic force microscopyDomínio/Área Científica::Engenharia e Tecnologia::Engenharia QuímicaCancer is still one of the major death causes worldwide demanding an urgent search for new therapies that combine selectivity, efficacy and ability to avoid resistance by cancer cells. One of the biggest advances in anticancer therapy is the use of antimicrobial peptides’ (AMPs) as chemotherapy drugs since some of them showed both antimicrobial activity and selective anticancer activity. In this work, the anticancer activity of three different AMPs, pepR, HNP-1 and PvD1, was tested against cancer and non-tumorigenic breast cell lines (MDA-MB-231 and MCF 10A). The cytotoxic activity of each peptide was evaluated by MTT tetrazolium assay and the determination of the half maximal inhibitory concentration (IC50), and showed that pepR and PvD1 act as anticancer peptides (ACPs), able to select between cancer and non-tumorigenic cells, whereas HNP-1 is not a promising ACP once it is not selective, killing both cell lines at the same concentration. Then, zeta-potential was used to evaluate the peptide-cell interaction and its effect in cells’ surface charge. In this case, surface neutralization is not required before cell death, contrary to what happens when these peptides act like AMPs. Finally, according with previous results, PvD1 was chosen as the most promising peptide and, as such, used for imaging assays with atomic force microscopy (AFM). With this technique height profiles and surface roughness were evaluated for both cell lines in absence and presence of three different PvD1 concentrations. It was concluded that, with the increase of peptide concentration there are no significant changes in cell’s height profiles. On the other hand, when analysed separately, nucleus and cytoplasm present surface roughness changes associated to the increasing of PvD1 concentration. Although it is not yet possible to propose a mechanism of action, both pepR and PvD1 are efficient against MDA-MB-231 cells and selective to MCF 10A cells.Castanho, MiguelGaspar, DianaRUNAlmeida, Inês Filipa de Oliveira2017-01-24T15:41:42Z2015-092017-012015-09-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/19894enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:02:29Zoai:run.unl.pt:10362/19894Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:25:46.907435Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Fighting breast cancer using membrane-active peptides
title Fighting breast cancer using membrane-active peptides
spellingShingle Fighting breast cancer using membrane-active peptides
Almeida, Inês Filipa de Oliveira
Anticancer peptide
Breast cancer
Membrane surface charge
Atomic force microscopy
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
title_short Fighting breast cancer using membrane-active peptides
title_full Fighting breast cancer using membrane-active peptides
title_fullStr Fighting breast cancer using membrane-active peptides
title_full_unstemmed Fighting breast cancer using membrane-active peptides
title_sort Fighting breast cancer using membrane-active peptides
author Almeida, Inês Filipa de Oliveira
author_facet Almeida, Inês Filipa de Oliveira
author_role author
dc.contributor.none.fl_str_mv Castanho, Miguel
Gaspar, Diana
RUN
dc.contributor.author.fl_str_mv Almeida, Inês Filipa de Oliveira
dc.subject.por.fl_str_mv Anticancer peptide
Breast cancer
Membrane surface charge
Atomic force microscopy
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
topic Anticancer peptide
Breast cancer
Membrane surface charge
Atomic force microscopy
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
description Cancer is still one of the major death causes worldwide demanding an urgent search for new therapies that combine selectivity, efficacy and ability to avoid resistance by cancer cells. One of the biggest advances in anticancer therapy is the use of antimicrobial peptides’ (AMPs) as chemotherapy drugs since some of them showed both antimicrobial activity and selective anticancer activity. In this work, the anticancer activity of three different AMPs, pepR, HNP-1 and PvD1, was tested against cancer and non-tumorigenic breast cell lines (MDA-MB-231 and MCF 10A). The cytotoxic activity of each peptide was evaluated by MTT tetrazolium assay and the determination of the half maximal inhibitory concentration (IC50), and showed that pepR and PvD1 act as anticancer peptides (ACPs), able to select between cancer and non-tumorigenic cells, whereas HNP-1 is not a promising ACP once it is not selective, killing both cell lines at the same concentration. Then, zeta-potential was used to evaluate the peptide-cell interaction and its effect in cells’ surface charge. In this case, surface neutralization is not required before cell death, contrary to what happens when these peptides act like AMPs. Finally, according with previous results, PvD1 was chosen as the most promising peptide and, as such, used for imaging assays with atomic force microscopy (AFM). With this technique height profiles and surface roughness were evaluated for both cell lines in absence and presence of three different PvD1 concentrations. It was concluded that, with the increase of peptide concentration there are no significant changes in cell’s height profiles. On the other hand, when analysed separately, nucleus and cytoplasm present surface roughness changes associated to the increasing of PvD1 concentration. Although it is not yet possible to propose a mechanism of action, both pepR and PvD1 are efficient against MDA-MB-231 cells and selective to MCF 10A cells.
publishDate 2015
dc.date.none.fl_str_mv 2015-09
2015-09-01T00:00:00Z
2017-01-24T15:41:42Z
2017-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/19894
url http://hdl.handle.net/10362/19894
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137888753942528